LANXESS stock: Q3 sales rise as cost savings lift earnings
Published on 11/13/2026 at 17:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSLANXESS earnings and outlook
- Third-quarter sales and EBITDA increased despite weak demand in several core markets.
- Specialty Additives delivered the strongest segment earnings growth, while Consumer Protection and Advanced Intermediates faced pressure.
- LANXESS expects full-year EBITDA pre exceptionals at the upper end of its EUR 450 million to EUR 500 million range.
LANXESS reported stronger third-quarter sales, EBITDA and free cash flow on November 5, while keeping its full-year outlook at the upper end of the existing range. The company said pricing and cost savings helped offset weak demand in several core markets, according to its third-quarter release.
Sales and cash flow improve
Sales rose 9.6 percent year over year to EUR 1.467 billion in the third quarter of 2026. EBITDA pre exceptionals increased 11.2 percent to EUR 139 million, lifting the margin to 9.5 percent from 9.3 percent a year earlier.
Free cash flow moved to positive EUR 48 million from negative EUR 14 million in the prior-year quarter. LANXESS attributed the improvement mainly to operating performance and cost-saving measures, while noting that agrochemicals, automotive and construction demand remained weak.
Segment results diverge
Specialty Additives was the strongest contributor. Segment sales increased 12.7 percent to EUR 569 million, while EBITDA pre exceptionals rose 57.8 percent to EUR 71 million. Higher selling prices and cost reductions lifted the margin to 12.5 percent from 8.9 percent.
Consumer Protection sales grew 8.4 percent to EUR 491 million, but EBITDA fell 6.9 percent to EUR 67 million. Advanced Intermediates sales increased 7.2 percent to EUR 404 million, while EBITDA slipped to EUR 25 million from EUR 26 million as energy, transport and weak end-market demand weighed on earnings.
Guidance points to stronger finish
LANXESS now expects full-year EBITDA pre exceptionals at the upper end of its EUR 450 million to EUR 500 million range. The group also expects positive free cash flow in the fourth quarter, making cash conversion and demand recovery important indicators for investors.
LANXESS stock traded at 13.16 euros on Lang & Schwarz at 17:46 CET on Friday, November 13, 2026, 0.08 percent above the Xetra close of Friday, November 13, at 13.15 euros. The quote was 13.13 euros at 08:06 CET in the earlier market report on the same day.
LANXESS stock at a glance
- Company: LANXESS AG
- ISIN: DE0005470405
- Ticker: LXS.DE
- Quoted price: 13.16 euros on Lang & Schwarz at 17:46 CET, November 13, 2026
- Change: 0.08 percent above the Xetra close of November 13, 2026
- Xetra close: 13.15 euros on November 13, 2026
- Market capitalization: 1,135,453,845 euros as of November 13, 2026
- Sector: Specialty chemicals
German equities remain an important backdrop for LANXESS investors. See Current market reports.
